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SUMMARY
Peroxiredoxins (Prxs) are ubiquitous cysteine-based peroxidases that guard cells against oxidative 
damage, are virulence factors for pathogens, and are involved in eukaryotic redox regulatory 
pathways. We have analyzed catalytically active crystals to capture atomic resolution snapshots of 
a PrxQ-subfamily enzyme (from Xanthomonas campestris) proceeding through thiolate, sulfenate, 
and sulfinate species. These analyses provide structures of unprecedented accuracy for seeding 
theoretical studies, and show novel conformational intermediates giving insight into the reaction 
pathway. Based on a highly non-standard geometry seen for the sulfenate intermediate, we infer 
that the sulfenate formation itself can strongly promote local unfolding of the active site to 
enhance productive catalysis. Further, these structures reveal that preventing local unfolding, in 
this case via crystal contacts, results in facile hyperoxidative inactivation even for Prxs normally 
resistant to such inactivation. This supports previous proposals that conformation-specific 
inhibitors may be useful for achieving selective inhibition of Prxs that are drug targets.
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INTRODUCTION
Peroxiredoxins (Prxs) are ubiquitous peroxidases and in humans and other mammals they 
modulate peroxide signaling events that regulate biological phenomena such as cortisol 
production, cell senescence, and apoptosis (Hall et al., 2009)(Wood et al., 2003)(Perkins et 
al., 2014)(Rhee et al., 2012)(Kil et al., 2012). Prxs utilize a highly efficient cysteine-based 
mechanism to reduce hydrogen peroxide, organic hydroperoxides, and peroxynitrite at rates 
contants on the order of 103–107 M−1 s−1 (Perkins et al., 2015). Though they perform 
catalysis in diverse ecological niches and redox environments, Prxs share a PxxxT/SxxC 
motif and conserved Arg (Nelson et al., 2010) that form a consistently organized active site 
(Fig. 1A, Fig. S1). The active site cysteine, referred to as the peroxidatic Cys (CP), is 
stabilized as a reactive Cys-thiolate (CP-S−) by the active site environment and attacks a 
bound hydrogen peroxide to form Cys-sulfenate (CP-SO−) and water (Perkins et al., 2015)
(Zeida et al., 2014)(Nagy et al., 2011)(Portillo-Ledesma et al., 2014). Most Prxs then 
undergo a substantial structural rearrangement to a locally unfolded (LU) conformation to 
allow CP to form a disulfide with a second, often distant, resolving Cys (CR). Subsequently, 
the CP-CR disulfide is reduced, commonly by thioredoxin, to regenerate the reactive CP-S− 
in the fully folded (FF) conformation (Perkins et al., 2015).
An additional complexity of Prx catalysis is a regulatory feature associated with further 
oxidation of CP: if the FF active site is sufficiently stabilized and unfolding inhibited, a 
second peroxide can inactivate the enzyme by reacting with the FF CP-SO− to 
“hyperoxidize” it to a Cys-sulfinate (CP-SO2−) (Wood et al., 2003). So-called ‘sensitive’ 
Prxs of mammals and other eukaryotes that are readily hyperoxidized are thought to use this 
shunt for purposeful substrate-induced inactivation that enhances redox signaling possibly 
through allowing peroxide to persist and oxidatively regulate downstream targets (Wood et 
al., 2003). Such organisms also possess the enzyme sulfiredoxin (Srx) to resurrect 
hyperoxidized Prxs (Perkins et al., 2014). In contrast, ‘robust’ Prxs such as those from 
bacterial pathogens are thought to only be used for oxidative defense and have been 
evolutionarily optimized to resist hyperoxidation, even at millimolar concentrations of 
peroxides (Wood et al., 2003)(Lowther and Haynes, 2010).
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Although previous studies have provided an excellent framework for understanding the Prx 
reaction pathway, important ambiguities remain regarding catalysis and hyperoxidation. 
Analysis of substrate-bound experimental structures (Hall et al., 2010) and computational 
studies (Zeida et al., 2014)(Nagy et al., 2011)(Portillo-Ledesma et al., 2014) have not 
yielded clarity about how the initial peroxidase step achieves a ~102–106 M−1 s−1 
enhancement over free thiol (Nagy et al., 2011), with recent studies proposing differences in 
the key interactions occurring between CP, the substrate, and the conserved Arg and Thr side 
chains (Fig. 1B–D)(Hall et al., 2010)(Zeida et al., 2014)(Portillo-Ledesma et al., 2014). Also 
poorly understood is the extent to which CP-SO− formation may promote local unfolding. 
Structural data for this state is limited to a few structures that do not show consistent 
interactions (Fig. S1), and due to the reactive nature of sulfenate/sulfenic acid, there can be 
uncertainty regarding the true redox state being observed (Perkins et al., 2013). The most 
thorough analysis to date comes from a study of four crystal structures (1.7 – 2.6 Å 
resolution) of the CP-SO− →CP-SO2− transition in Aeropyrum pernix thiol peroxidase 
(ApTpx) that reported an unexpected CP-sulfurane-His intermediate; but most Prxs do not 
contain this His residue, so such an intermediate cannot be present for the majority of Prxs 
(Nakamura et al., 2008).
To work towards resolving discrepancies in proposed peroxidation mechanisms and 
elucidate the relevant structural details important for unfolding and hyperoxidation, we 
sought a model system that could provide high resolution snapshots of Prx catalysis at all 
stages (e.g. CP-S− ; CP-SO− ; CP-SO2− ; the CP-CR disulfide ; and FF and LU 
conformations). We chose for this purpose Xanthomonas campestris peroxiredoxin Q 
(XcPrxQ). The PrxQ subgroup (formerly called BCP) is found in diverse organisms 
including bacteria, archaea, plants, and fungi, but not animals (Perkins et al., 2015)(Nelson 
et al., 2010), and some members of this subgroup have been shown to be important for 
pathogen defenses (Perkins et al., 2014). XcPrxQ was attractive for several reasons: (1) it 
possesses active site features common to the majority of Prxs; (2) as a monomeric Prx, it is 
more amenable to NMR and computational analyses; (3) it has yielded high resolution 
structures of an FF form (a CP/CR→Ser double mutant at 1.5 Å, PDB entry 3gkm), and an 
LU disulfide form (1.8 Å, PDB entry 3gkk) (Liao et al., 2009); and (4) the FF crystal form 
had an accessible active site, potentially enabling in-crystal studies of ligand binding and 
catalysis. XcPrxQ has its CR residue in helix α3, and undergoes a FF→LU conformation 
change involving the flipping of the CP side chain and an unraveling of α3 (Liao et al., 
2009) (see Figure 3A).
Using this system, we have recently published the NMR backbone assignments for the 
reduced and oxidized states (Buchko et al., 2015) and here we report crystallographic studies 
that include analysis of wild-type crystals that are catalytically active and diffract better than 
anticipated. We have been able to capture at atomic resolution a full series of novel wild-
type XcPrxQ structures that encompass the complete CP-S− → CP-SO− → CP-SO2− 
transition and provide novel insights into Prx catalysis. The in-crystal behavior also 
demonstrates the extent to which even a robust bacterial Prx can be made highly sensitive to 
hyperoxidative inactivation.
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RESULTS AND DISCUSSION
Recombinant wild type XcPrxQ as well as its CP → Ser (C48S) and CR → Ser (C84S) 
mutants were prepared in good yields and behaved well in analyses (see Experimental 
Procedures). In addition to basic functional characterization of the wild type enzyme we 
report 15 crystal structures refined at resolutions of 1.0 – 1.35 Å (Table 1, Table S1) that 
include a series of 12 novel structures of the catalytically active crystals of the FF wild type 
enzyme at various stages along the catalytic cycle, and one novel structure each of the C48S 
and C84S mutants, and the wild type enzyme disulfide form solved at ~0.5 Å higher than in 
a previous study (Liao et al., 2009).
Basic functional characterization of XcPrxQ
In a standard Prx assay system, recombinant XcPrxQ reduced hydrogen peroxide and 
organic peroxides with kcat/Km values of ~3 × 104 M−1 s−1 (Fig. 2A–B, Table S2). This level 
of activity is typical for PrxQ representatives, which range from 0.8 × 104 to 4 × 104 M−1 
s−1 (Reeves et al., 2011)(Rouhier et al., 2004)(Horta et al., 2010). The recombinant XcPrxQ 
was also relatively resistant to hyperoxidation in solution as is typical for bacterial Prxs (Fig. 
2C–F) (Nelson et al., 2013). Quantifying the sensitivity using the Chyp1% metric, which 
indicates the peroxide concentration at which 1% of the enzyme molecules will be 
oxidatively inactivated per turnover (Nelson et al., 2013), XcPrxQ has a value of 1.4 mM, 
and so is roughly 20-times more robust than human Prx I and 7 times less robust than S. 
typhimurium AhpC (Fig. 2F, Table S2).
High Precision Views of the FF and LU Active Sites
By pretreating the recombinant enzyme with dithiothreitol (DTT) we were able to grow FF 
crystals of the authentic reduced wild type form (Fig. 3A). These crystals diffracted to ~1.0 
Å resolution, the best resolution so far for any Prx (Fig. S1). We were also able to replicate 
the crystals of the LU disulfide form (Fig. 3A) and extend their resolution to ~1.3 Å. For 
these structures, the high-quality electron density (Fig. 3B–C) clearly defines the active site 
geometry and allows us to precisely define, in the context of this model system, the active 
site interactions present in the substrate-ready FF active site (Fig. 1A–B) as well as those 
present in the disulfide form. In the unreacted protein, CP (Cys48) interacts closely with the 
Arg123 side chain, the Lys42 backbone NH, and two water molecules that roughly mimic 
the oxygens of a peroxide substrate (Fig. 1A & 3B). The structure of C48S (i.e. CP→Ser) 
looks nearly the same but has a bound phosphate that displaces the waters to similarly mimic 
substrate binding (see Fig. 5C). Like other Prx crystal structures (Hall et al., 2010), the wild 
type structure has the Thr45 side chain positioned to donate a hydrogen bond to the Lys42 
carbonyl oxygen and not to the Cys48-Sγ (O···O distance of 2.9 Å, Thr-CB-Oγ···O-Lys42 
angle = 114°) (Fig. 1A & 3B). This consistent high precision positioning of Thr45 matches 
that seen in previous Prx structures (Hall et al., 2010), but contrasts with computational 
studies that have modeled the conserved Thr as donating a hydrogen bond to the Cys thiolate 
and/or substrate oxygen (Zeida et al., 2014)(Portillo-Ledesma et al., 2014) (Fig. 1B–D). We 
further observe that rather than bonding directly to the thiolate or ligand, the distal Arg NH 
is oriented at an intermediary position where it could stabilize the transition of the peroxide 
oxygen to the Cys Sγ (Fig. 1B–C, Fig. 3B).
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Structures along the Reaction Path
Since the crystalline wild type protein, unlike the CP→Ser mutant, is theoretically capable 
of catalysis if permitted by the crystal environment, we soaked the crystals with hydrogen 
peroxide, cumene hydroperoxide, and t-butyl hydroperoxide and found no loss in diffraction 
quality and conversion of CP to the CP-SO2− form (Fig. 4A,D and Fig. S2). After conducting 
initial experiments at pH 7.0, we performed additional substrate soaks varying peroxide 
concentrations and soak time, and also adjusted the pH to 4.5 speculating that a higher 
portion of protonated CP (CP-SH) could slow the reaction and allow us to better capture 
intermediates along the reaction pathway. This was successful and from a large set of 
structures solved, we selected a series of nine ~1 Å resolution structures – named FF0 
through FF8 – that provide representative details of the transition of this Prx from CP-S− 
through CP-SO− to CP-SO2− (Fig. 4; Tables 1 and S1); a tenth structure, FF9, provides a 
fully-occupied CP-SO2− reference structure at pH=7. The FF0, FF3, FF5 and FF8 structures 
(Table 1) provide the best views of the CP-S− (occupancy ~1), CP-SO− (occupancy ~0.5), 
‘inverted’ CP-SO− (occupancy ~0.1), and CP-SO2− (occupancy ~1) forms. The atomic 
resolution of these structures, with coordinate uncertainties of <0.05 Å, allow for a powerful 
dissection of the details of catalysis, including the reliable recognition of low occupancy 
intermediates and alternative conformations of active site residues.
Peroxidation (FF1 through FF3)—A known value of ultra-high resolution 
crystallography is its ability to provide definitive evidence for unexpected structures. Here, 
we were surprised that the clearly defined putative SO− intermediate is stabilized in the 
crystal with a Cβ-Sγ-Oδ bond angle of 153° (compared to the expected ~110 degrees (Engh 
and Huber, 1991)) and a short 1.38 Å Sγ-Oδ bond length (Fig. 5A,B). To our knowledge, 
such a bond angle has not been previously observed for a Cys-sulfenate. This is a reliable 
crystallographic result as we observed it in seven independent crystal structures: five H2O2 
soaks at pH 4.5, one H2O2 soak at pH 7.0, and one t-butyl hydroperoxide soak at pH 7.0. 
The only standard hydrogen bond visible to the SO− oxygen is from Arg123, but the moiety 
as a whole is fully surrounded by a tightly packed and well-ordered active site with low B-
factors (Figs. 5A and 3A) that changes little between oxidation states. The presence of the 
sulfenate Oδ causes a conformation change of Pro41, which flexes from an exo to an endo 
rotamer to avoid a steric clash (Fig. 5B). Importantly, the change in Pro41 is also at half 
occupancy matching that of the SO− oxygen. Interestingly, with this change the Pro41-CδH 
atom is positioned to make a C-H hydrogen bond (Derewenda et al., 1995) to the SO− 
oxygen (Fig. 5A). In a fortuitous related result, the structure of the C48S mutant contains a 
fully bound water in roughly the same position as the SO− oxygen, and it similarly induces 
the Pro41 conformation change (Fig. 5C). This C48S structure provides evidence that 
despite the lack of multiple strong conventional hydrogen bonds, this is a 
thermodynamically favorable position for oxygen binding.
To better understand how this intermediate could adopt such an unexpected bond angle and 
length, we performed gas phase quantum mechanical (QM) computations of a variety of 
model methyl SOH and SO− species (Figs. 5D, S4 and S5). These species incurred severe 
energetic penalties to adopt the observed geometry (~40–50 kcal/mol). Interestingly, a 
doubly protonated methyl SH2O− sulfenate species only exhibited ~9 kcal/mol of energetic 
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penalty for adopting the 153° angle (Fig. 5D). As we mentioned above, an Arg123-NH and a 
backbone amide (Lys42) provide universally conserved hydrogen bond interactions to the Sγ 
atom (Figs. 1A and 5A), and the geometry of these hydrogen bonding interactions are such 
that they may cause electronic effects that are similar to those caused by the double 
protonation. So while further studies are certainly needed to fully understand the nature of 
the structure seen, we hypothesize that the electrostatic (including hydrogen bonding) 
environment of the active site may help make this structure energetically accessible.
Hyperoxidation (FF4 through FF8)—Fortuitously, our model system allowed us to not 
only capture each chemical state of the catalytic cycle, but also aspects of the transition from 
CP-SO− to the hyperoxidized CP-SO2− state (Fig. 4). In particular, structures FF4 through 
FF7 give evidence of a predicted (Hall et al., 2010) intermediate along this reaction pathway 
in which the SO− rotates inward toward Arg123 to adopt what we call an ‘inverted’ position, 
and vacates the substrate binding site to permit reaction with a second peroxide. To 
accommodate the inverted sulfenate oxygen the side chain of Arg123 flips out of the active 
site and away from CP (Fig 4C). Upon reaction with the second peroxide, Arg123 
repositions to a third conformation to coordinate with the oxygens of the newly formed CP-
SO2− (Fig. 4D). Interestingly, we note for this bacterial Prx that both the inverted CP-SO− 
and CP-SO2− reaction states along the hyperoxidation pathway perturb the Arg from its 
normal catalytic position.
Since XcPrxQ in solution is rather robust against hyperoxidation (Fig. 2F, Table S3), it was 
surprising that the protein in the crystal was so readily hyperoxidized and that the CP-SO− 
only accumulated to a maximal level of ~50%. In fact, for crystalline XcPrxQ the protein 
becomes fully hyperoxidized (with no disulfide formation) in a single turnover whereas only 
~7 % would be expected to become hyperoxidized in solution at the same peroxide 
concentration (Fig. 2F). This can be easily understood in that crystal contacts block the 
protein from ever unfolding, effectively dropping the rate of disulfide bond formation to zero 
in the crystal compared with the solution rate of ~27 s−1 (Table S2). In fact, crystal contact 
interactions occur at all four regions involved in local unfolding (Fig. 6A). While we cannot 
dissect how much each crystal contact contributes, we note that at one contact, Arg103 of a 
symmetry mate directly blocks disulfide formation by preventing rearrangement of the CR-
containing α3 helix (Fig. 6B).
Modulating the switch between local unfolding and hyperoxidation pathways
Susceptibility of Prxs to hyperoxidation and inactivation is of broad biological signicance, as 
to survive pathogens must avoid having their Prxs inactivated by host-secreted reactive 
oxygen species, and inactivation is required as part of eukaryotic signaling pathways 
(Perkins et al., 2014). The structures reported here provide insight into the structural features 
involved in determining whether the protein in the CP-SO− state will undergo local 
unfolding or become hyperoxidized. For bacterial XcPrxQ, several lines of evidence indicate 
that sulfenate formation is destabilizing to the active site and promotes local unfolding. 
Initial formation of the sulfenate in XcPrxQ resulted in a high energy CP-SO− structure. As 
to why this sulfenate deviates so significantly from its ground state geometry, the main thing 
we notice is that the FF active site changes minimally between the thiolate (S−) and 
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sulfenate (SO−) forms (Fig. 5C), and that within an unperturbed FF active site, the CP-SO− 
sulfenate oxygen appears to be sterically and electrostatically hindered by the Thr45 side 
chain from adopting a relaxed position (Fig. 5A). We expect that in solution the unfavorable 
interactions would be releaved by local unfolding of the active site and facilitate formation 
of the CP-CR disulfide, and we only observe this high energy conformation in the crystalline 
enzyme because of the stabilization of the FF active site conferred by the crystal contacts. 
Stated another way, for sulfenate formation there are two possibilities: the CP-SO− adopts a 
relaxed geometry while perturbing the FF active site (i.e. promoting local unfolding) or the 
FF active site remains intact and the CP-SO− adopts a high energy conformation compatible 
with its environment.
Interestingly, it has been observed that adopting a ground state sulfenate geometry perturbs 
the active site for Prxs from two other subfamilies. For human Prx6 (PDB entry 1prx)(Cao et 
al., 2011) the conserved Arg is swung away to make room for the modification, and for 
Mycobacterium tuberculosis AhpE (PDB entry 1xwv), a 1-Cys Prx, changes occur for both 
Arg and Thr positions (Li et al., 2005). Lastly, the tradeoff between sulfenate conformation 
and active site stability may explain the origin of the unusual hypervalent CP-sulfurane-His 
intermediate formed in peroxide soaks of crystals of the A. pernix thiol peroxidase 
(Nakamura et al., 2008); perhaps the intermediate is a high energy structure that forms in the 
crystal only because crystal contacts hinder the local unfolding that would normally be 
promoted by CP-SO− formation.
A second structural determinant revealed in the XcPrxQ structures is how the transient 
inverted CP-SO− affects the active site of a robust bacterial Prx. The rotation of the sulfenate 
oxygen to point back into the tightly packed active site causes the Arg to flip outward. 
Similar to the unfavorable geometry observed following initial peroxidation, these 
rearrangements would appear to promote local unfolding for the protein, and could also 
reduce the rate of hyperoxidation by removing the Arg’s contributions to substrate binding 
and activation. Interestingly, we do not see the Arg to shift in response to an inverted oxygen 
position in sulfinate structures from sensitive Prx enzymes, such as human PrxII (PDB entry 
1qmv)(Kitano et al., 2005), implying that sensitive Prxs could in part favor hyperoxidation 
over local unfolding by having evolved to better accommodate the inverted oxygen position 
in an FF active site.
Overall, the hyperoxidation pathway observed in the XcPrxQ structures reveal there are at 
least three ways the sensitivity of a Prx isoform can be tuned. First, hyperoxidation can be 
hindered if CP-sulfenate formation directly destabilizes the FF active site through 
unfavorable steric and electrostatic interactions, favoring local unfolding and promoting 
disulfide formation. Second, hyperoxidation can independently be further disfavored if the 
FF active site is destabilized when the sulfenate oxygen rotates to the inverted position and 
makes room for the second peroxide substrate to bind. Third, an enhancement of 
hyperoxidation can be accomplished through any set of interactions that disfavor local 
unfolding. In naturally sensitive Prx1 subfamily enzymes, a C-terminal extension buttresses 
and stabilizes the FF active site to inhibit unfolding and disulfide formation (Wood et al., 
2003)(Perkins et al., 2014), and in the XcPrxQ crystals the functional equivalent of these 
interactions are the crystal contacts. An intriguing possibility is that this functionality could 
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be exploited to design conformation-trapping inhibitors to selectively target pathogen Prxs 
(Perkins et al., 2014) (Perkins et al., 2013). The advantage conferred by this strategy is that 
differences in FF↔LU conformational changes between human and pathogen isoforms 
could be leveraged to design inhibitors that bind regions other than the conserved active site, 
avoiding the potential for toxicity from disrupting human Prx function.
CONCLUSION
In summary, the ultra-high resolution structures reported here reveal in the context of 
bacterial XcPrxQ an unprecedented level of detail about active site interactions covering the 
full cycle of Prx catalysis (Fig. 6C). These structures directly add to our knowledge of the 
Prx mechanism, and will serve as ideal starting models for future computational studies of 
both the initial peroxidation reaction and hyperoxidative inactivation. An unusual Cys-
sulfenate geometry is observed (<Cβ-Sγ-Oδ = 153º) that quantum mechanical computations 
reveal incurs a severe energetic penalty that may be made more energetically accessible in 
the presence of strong hydrogen-bonds to the Sγ. From these results, we hypothesize that 
formation of the high energy sulfenate potently induces the active site to locally unfold. 
Additionally, although several computational studies by others have modeled the conserved 
Thr as donating a hydrogen bond to the Cys thiolate and/or substrate oxygen (Zeida et al., 
2014)(Portillo-Ledesma et al., 2014), consistent with previous structural studies of other 
Prxs (Hall et al., 2010) we find no evidence for such an interaction in the atomic resolution 
structures of XcPrxQ. Perhaps some of these discrepencies may be due to the exclusion of 
the universally conserved Pro and surrounding residues in earlier computational studies. 
Indeed, as with all model systems, the beneficial ease and simplicity of analysis conferred by 
aspects of XcPrxQ functionality come at the cost of limitations that some Prxs, a family that 
includes members separated by billions of years of evolution, may behave differently. Our 
structures here most directly represent the behavior of a robust bacterial Prx and further 
work will be required to explore how similar our observations are across the very diverse Prx 
family. However, we note that the XcPrxQ model system has the key Pro, Thr, Cys, and Arg 
residues conserved across all Prxs, and so we expect should be representative of the 
peroxidatic step, even though isoforms vary in the manner they locally unfold and in their 
susceptibility to hyperoxidation.
EXPERIMENTAL PROCEDURES
Materials & Methods
Cloning, Expression, and Purification—The gene for XcPrxQ, codon-optimized for 
expression in E. coli and synthesized by GenScript (Piscataway, NJ), was cloned between 
the NcoI and HindIII sites of pTHCm(Nelson et al., 2008) to express a non-His-tagged 
protein. Mutations were created using the QuikChange II method (Agilent). Expression was 
carried out in strain B834, using ZYM-5052 auto-induction medium at 37 °C (Studier, 
2005). Purifications were done at 4 °C. Cells were disrupted using an Avestin C5 
homogenizer, nucleic acids removed using streptomycin sulfate, and after overnight dialysis 
against 10 mM Tris-Cl, pH 8.0, 0.5 mM EDTA and centrifugation, the supernatant was 
loaded onto a 75 mL Q-Sepharose HP (GE Healthcare) column. XcPrxQ was eluted using a 
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0→1 M NaCl gradient, with XcPrxQ-containing fractions precipitated at 75 % saturating 
ammonium sulfate. The protein pellet was dissolved in a minimal volume of 25 mM 
potassium phosphate, pH 7.0, 1 mM EDTA and 0.1 M NaCl, and loaded onto a 250 mL 
Superose 12PG (GE Healthcare) column equilibrated with the same buffer. For assays, pure 
protein was buffer-exchanged into 20 mM Tris-Cl, pH 8.0, 1 mM EDTA, and concentrated 
to 10 mg ml−1 by ultrafiltration, and frozen at −80 °C in aliquots. E. coli thioredoxin 1 
(TrxA) and thioredoxin reductase (TrxR) were expressed and purified as previously 
described (Reeves et al., 2011).
Crystallography
Crystallization: After exchanging the wild type protein into 20 mM Tris pH 7.0, 20 mM 
sodium chloride, 1 mM EDTA, protein at 10 mg/ml was initially crystallized using 
conditions from Liao et al. (Liao et al., 2009). Crystal seeding greatly increased crystal size 
and growth rate. For wild type XcPrxQ in the locally unfolded disulfide form (LUss) optimal 
growth at 300 K occurred within three days in 4:1 protein:reservoir drops with a reservoir of 
1.0 M ammonium sulfate, 0.2 M sodium chloride, 0.1 M sodium cacodylate, pH 6.8. From 
stacks of plate-like crystals, single plates were extracted into a 10 μL drop of AML 
containing a cryoprotectant of 4.5 M sodium formate, equilibrated for three minutes, then 
scooped and plunged into liquid nitrogen. Attempts at reducing the disulfide by chemical 
reductants were unsuccessful.
For initially crystallizing wild type XcPrxQ in the fully folded form (FF), the protein was 
pre-treated for 10 minutes with 10 mM DTT, and 10 mM fresh DTT was added to the 
condition previously reported to crystallize the C48S/C84S double mutant (Liao et al., 
2009). After optimization, crystals were grown at 300 K in 6:2 μl protein:reservoir hanging 
drops with 8 mg/ml protein stock and a reservoir of 30% PEG 4000, 0.1 M sodium acetate 
pH 5.5, 10 mM DTT. Individual crystals were transferred to fresh 10 μL drops containing an 
AML of 18% PEG 4000, 0.1 M Tris, pH 7.0, and 4.5 M sodium formate, equilibrated for 
three minutes, scooped and plunged in liquid nitrogen.
For the wild type FF crystals, time courses at pH 7.0 were conducted with 10 mM t-butyl 
hydroperoxide or cumene hydroperoxide, and at pH 4.5 or 7.0 with 10 mM hydrogen 
peroxide, in a 10 μL drop. Substrate soaks were performed at 300 K by adding 1.0 μL of an 
100 mM peroxide stock to a crystal-containing drop of 9 μL of AML with either 0.1 M 
sodium acetate (pH 4.5) or 0.1 M Tris (pH 7.0), and after between 5 s and 10 mins scooping 
and plunging the crystal into liquid nitrogen. A 10 mM substrate concentration was chosen 
as an amount that would not readily oxidize other residues non-specifically (Drozdź et al., 
1988) but was enough to readily oxidize CP. That lower concentrations such a 1 mM did not 
consistently succeed can be explained by recognizing that for average crystals of ~1 × 0.5 × 
0.2 mm3 (containing ca. 1.4 × 1015 XcPrxQ molecules), 1 mM peroxide in a 10 μL drop 
only provides roughly a 4:1 ratio of peroxide to protein. Due to the varying size and shapes 
of crystals, soak duration was only roughly correlated with the redox state observed in the 
structure. For this reason, we collected data on crystals with many different soak times to 
obtain structures for reaction intermediates.
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The C48S and C84S single mutants crystallized in similar conditions to the wild type FF, in 
a protein buffer of 25 mM potassium phosphate, pH 7.0, 1 mM EDTA and 0.1 M NaCl. 
Optimal conditions for C48S were 3:1 μL protein:reservoir drops using a 6 mg/ml protein 
stock and a 40% PEG 4000, 0.1 M sodium acetate pH 5.5 reservoir. C84S crystallized in 4:1 
μL protein:reservoir drops with 9.2 mg/ml protein stock and a reservoir of 35% PEG 4000, 
0.1 M sodium acetate pH 5.5, 1 mM DTT. The C84S structure demonstrated no major 
differences other than a shift in the Ser position relative to the wild type Cys (Fig. S3), but 
we have included it here as it is the highest resolution structure for a CR mutant form and 
may be useful for future studies. As for wild type, these crystals were generally equilibrated 
in a 10 μL drop of AML at pH 7.0 prior to freezing. The one exception was a C48S crystal 
harvested directly from its drop (at pH 5.5) that yielded the phosphate-bound structure. 
Crystals of wild type and C84S scooped directly from their drops did not yield phosphate-
bound structures.
Data Collection: Data were collected at the Advanced Light Source at Lawrence Berkeley 
National Labs on beamlines 5.0.1, 5.02, and 5.03 at cryo-temperatures. Data were indexed 
and integrated with iMosflm 7.0.9 (Battye et al., 2011), and found to be in the two expected 
P21 crystal forms for LUss (wild type) and FF crystals (yielding wild type, C48S, and C84S 
structures) (Table 1, Table S1)(Liao et al., 2009). Though both crystal forms coincidently 
have P21 symmetry, they have different unit cells and crystal packing interactions.
Refinement: For the FF structures, the main initial changes from entry 3gkm were the 
addition of ca. 100 water molecules now visible with the improved resolution and an 
alternate chain path for residues 65–67. Additionally, mass spectrometry implied the N-
terminal methionine had been lost and an acetyl group gained, and this modification was 
reasonably clear in the electron density and was modeled. Several solvent sites exhibiting 
strong electron density and close bond distances of ~2.1 Å were modeled as Na+ ions, 
present in the protein buffer, crystallization conditions, and cryoprotectant. Continuous 
density near Cys84 may be a disordered PEG molecule, but was left unmodeled. Strong 
density for a tetragonal ligand was seen in the C48S active site at pH 5.5. This was modeled 
as a phosphate since the protein buffer contained 25 mM phosphate and because anomalous 
maps showed strong peaks for cysteine sulfur atoms but no signal at the ligand peak. In late 
stages of refinement, riding hydrogens were added, reducing Rfree by ~1 %. Subsequently, 
individual anisotropic B-factors were introduced for all non-hydrogen atoms, reducing Rfree 
by a further 2–3 %.
For wild type structures treated with substrate, the occupancies of oxygen adducts were 
estimated from the relative strength of the electron density, with the expectation that B-
factors would be slightly higher for the oxygen positions than the Sγ, the requirement that 
occupancies must add to 100%, the knowledge of the atom positions in the thiolate, 
sulfenate, and sulfinic acid forms based on clear high occupancy structures for each of those, 
and also using information from active site rearrangements that appear to be correlated with 
the redox changes at CP. The final occupancies chosen also minimized residual difference 
peaks. We could not explicitly distinguish between sulfenate and sulfenic acid forms which 
differ by only a hydrogen (for example between alternate conformations of sulfenate and 
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low occupancy sulfinate). We tested if the extended sulfenate angle could be the result of 
radiation damage from data collection, but analysis of only the first 90 diffraction images 
still show the clearly-defined adduct.
Quantum mechanical computations—All quantum mechanical computations were 
performed in the gas phase using M06-2X(Zhao and Truhlar, 2008)/6-31G*(Miertuš et al., 
1981) level of theory as implemented in Gaussian 09.(Frisch et al., 2009) Ten methyl 
sulfenate (SO−) and sulfenic acid (SOH) species of varying oxidation and protonation states 
were computed for a series of geometries with varying C-S-O angles from 95º to 155º in 5º 
increments (Figs. 5D, S4, & S5). For the methyl SOH species, the torsional angle around the 
S-O bond was rotated 360º in 10º increments for each C-S-O angle increment to capture the 
minimum energy pathway We benchmarked M06-2X/6-31G* results against energies from 
fifteen quantum mechanical methods including the high accuracy DLPNO-CCSD(T) (Fig. 
S5). The employed method yields consistent results at a lesser computational expense.
Measurement of Kinetic Properties—XcPrxQ activity was measured by following the 
decrease in fluorescence of E. coli thioredoxin, TrxA, as the reductant of XcPrxQ in reaction 
mixtures with H2O2 or cumene hydroperoxide, as described by Parsonage et al (2010) 
(Parsonage et al., 2010). Values for Vmax and Km for both peroxide and TrxA substrates 
were calculated directly from global fits of all of the data for each peroxide substrate by 
using the multiple-function nonlinear regression capability of SigmaPlot (SYSTAT software)
(Parsonage et al., 2010). The kinetic data using were fit to a model of saturable interactions 
(defined KM) for each substrate, but the KM for interaction of EcTrxA with XcPrxQ is not 
well determined given the concentrations used (Table S2). Steady state kinetic parameters 
from these global fits are reported in Table S2.
Hyperoxidation of XcPrxQ (1 μM) was measured in the presence of 1 μM EcTrxA, 0.1 μM 
EcTrxR, 150 μM NADPH, and either CHP or H2O2 (0.1, 0.2, 0.5, 1, 2, and 5 mM) in 25 mM 
potassium phosphate, pH 7.0, 1 mM EDTA, 100 mM ammonium sulfate at 25 °C with a 
Varian Cary 50 UV-Vis spectrophotometer by monitoring absorbance at 340 nm. As the Prx 
protein becomes hyperoxidized over the course of the reaction (with a fraction inactivated 
during each turnover), the absorbance change over time increasingly deviates from linear 
kinetics. The kinetic trace was fit to an exponential decay model to describe inactivation 
sensitivity using the previously introduced Chyp1% metric, which indicates the peroxide 
concentration at which 1% of the enzyme molecules will be oxidatively inactivated per 
turnover(Nelson et al., 2013). Steady state kinetic parameters from these global fits are 
reported in Table S2. Inactivation of XcPrxQ over 15 min during turnover with peroxide 
concentrations in excess of 0.1 mM was detectable and yielded a Chyp1% value of 1.43 mM 
for H2O2 (Table S3).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
Prx peroxiredoxin
TrxA thioredoxin 1
Srx sulfiredoxin
PDB protein databank
CP peroxidatic cysteine
CR resolving cysteine
FF fully folded
LU locally unfolded
XcPrxQ Xanthomonas campestris peroxiredoxin Q
ML mother liquor
AML artificial mother liquor
ρrms root-mean-square electron density
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Figure 1. 
Summary of proposed mechanisms of Prx peroxidation. A. Overlay of active sites of DTT-
bound human PrxV (light blue) and peroxide-bound ApTpx (green) with water-bound wild-
type XcPrxQ (white), with ligands colored cyan (DTT), lime (H2O2), and dark gray 
(waters), respectively. Dashed lines indicate active site interactions for XcPrxQ, including a 
contact between the CδH of Tyr40 with the thiolate that would also contribute weak 
electrostatic stabilization to the thiolate. This appears to be a conserved interaction in FF Prx 
structures and involves either a Tyr or His. B–D. Previous studies do not provide a consensus 
on how Prx catalysis proceeds, as evident by the many different hydrogen bond interactions 
and residue shifts proposed. Hydrogen bonds seen in the XcPrxQ structures in this study 
(dark gray arrows pointing from donor to acceptor) for the substrate-bound state, the inferred 
transition state (based on relative rigidity of active site residues), and the product states, are 
compared with those proposed by previous studies: brown arrows for Hall et al. (Hall et al., 
2010), blue arrows for Portillo et al. (Portillo-Ledesma et al., 2014), green arrows for Zeida 
et al. (Zeida et al., 2014), and pink arrows for Nagy et al. (Nagy et al., 2011). Shifts in 
residue positions are noted by thick arrows (Thr shift in blue panels C/D and Pro shift in 
dark gray in panel D). Forming and breaking covalent bonds are depicted as double dashed 
lines. Atoms not incorporated into previous QM simulations, presumably because they were 
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not thought to play key roles in the chemistry of catalysis, are highlighted in yellow in panel 
B. The circled hydrogen and dashed arrow in panel D notes a predicted proton transfer by 
Portillo et al. (Portillo-Ledesma et al., 2014). See also Fig. S1 for an analysis of available 
Prx crystal structures.
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Figure 2. 
In solution kinetics of XcPrxQ. A. Bisubstrate kinetics of XcPrxQ (0.2 μM) with hydrogen 
peroxide and EcTrxA at 5 μM (black), 10 μM (red), 20 μM (green) and 40 μM (blue). The 
curves are the results of the global fitting of all four data sets. B. Same as A, but for cumene 
peroxide and EcTrxA at 5 μM (black), 10 μM (red), 20 μM (green) and 50 μM (blue). C–D. 
Time courses showing XcPrxQ hyperoxidative activity loss during reactions with varying 
concentrations (as indicated) of hydrogen peroxide and cumene hydroperoxide, respectively. 
E. The fraction of protein inactivated per turnover (Wood et al., 2003) (finact) is plotted as a 
function of peroxide concentration for XcPrxQ hyperoxidation by hydrogen peroxide 
(closed circles) and cumene peroxide (open circles). F. Sensitivity of XcPrxQ to 
hyperoxidation by hydrogen peroxide (closed circles) is compared to literature data (Nelson 
et al., 2013) for human PrxI (open squares) and Salmonella typhimurium AhpC (open 
circles). See also Table S2 and Table S3.
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Figure 3. 
Fully Folded and Locally Unfolded Conformations of XcPrxQ. A. The active FF 
conformation (left) and the LU disulfide conformation are shown (right) as cartoons colored 
by local mobility as indicated by B-factor, and with sticks for CP, CR and the conserved 
active site Pro, Thr and Arg. The largest conformation changes involve the helix 3 region 
that is highlighted in yellow. This structural rearrangement moves CP away from the active 
site pocket, disrupting all of its hydrogen bonding interactions, as described by Liao et al. 
(Liao et al., 2009). B. The active site of the XcPrxQ FF structure with 2FO-FC density (thin 
blue mesh 1.5 ρrms pink mesh 3.5 ρrms). C. Same as B but for the LU CP-CR disulfide 
structure.
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Figure 4. 
Atomic resolution snapshots of XcPrxQ catalysis. A–D. Structures FF0, FF3, FF5 and FF8, 
respectively, are shown with their 2FO-FC electron density (blue contoured at 1.0 ρrms) and 
difference electron density between the structure of interest and FF0 (green and red 
contoured at ±3.0 ρrms). In panels B–D, key shifts in active site residues are indicated by 
brown arrows with the conserved Pro flipping between two positions (noted as P1 and P2) 
and the Arg transitioning among three positions (R1, R2, R3). E. CP is shown with 
occupancies of its oxygen adducts indicated by color (from light to dark red). 2FO-FC 
density is shown (blue contoured at 1.0 ρrms and for the sulfenate oxygen in FF1 olive 
contoured at 0.3 ρrms). Density near the top of the image in structures FF4–FF7 is from a 
partially-occupied Arg conformation that occurs as the protein converts from the sulfenate to 
sulfinate state. F. A single image showing the 2FO-FC electron density peaks for CP oxygens 
from all structures as single planes (solid colors at 1.0 ρrms, red outline 0.3 ρrms). The 
overlay shows the progression of the oxidation of CP: from 10% SO− (red outline; FF1), 
45% SO− (orange; FF2), 50% SO− (yellow; FF3), 10% SO2− (light green; FF4), 20% SO2− 
(cyan; FF5), 20% SO2− (blue; FF6), 35% SO2− (dark blue; FF7), 100% SO2−, (purple; FF8). 
All structural images were prepared using Pymol. See also Figure S3 and Figure S4.
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Figure 5. 
Unusual Cys-sulfenate geometry. A. Packing interactions of the Cys-sulfenate are shown for 
structure FF3, highlighting interactions with the Cys-Sγ (gray dashes and distances in Å), 
with the sulfenate oxygen (black dashes and distances), and a possibly unfavorable 
interaction between Thr45-OH and the CP-SO− (red dash and distance). 2FO-FC electron 
density evidence for the sulfenate position is also shown (blue contoured at 1.0 ρrms). B. 
Interaction of the CP-thiolate with Pro41 (upper image) compared with that of the CP-
sulfenate (at 0.5 occupancy and labeled with its unusual bond angle and distance reported; 
lower image). A brown arrow shows the shift of Pro41-Cγ accommodating the sulfenate 
formation by relieving a steric clash (red double-headed arrow) to increase the Pro41-Cγ to 
sulfenate oxygen distance to 3.6 Å. C. Structure of C48S XcPrxQ including bound water 
and phosphate (pink model) is compared with the XcPrxQ thiolate (FF0) and XcPrxQ 
sulfenate (FF3) forms (similar models both with white carbons; FF0 waters are gray spheres) 
and peroxide bound ApTpx (PDB code 3a2v, green carbons). Shift of the Pro is noted with a 
brown arrow. Notable observations are the C48S water and phosphate being near the FF3 
Cys-sulfenate oxygen and the ApTpx peroxide, respectively. D. Gas phase quantum 
mechanical calculations (Zhao and Truhlar, 2008) of methyl SO−, SH2O+, and SH2O− 
species showing their energies as a function of their C-S-O bond angle (upper panel) as well 
as the optimized geometries and energies for the structures constrained to have a C-S-O 
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angle of 155º. 3D figures were generated using CYLview (Legault, 2009). See Figures S4 
and S5 for supporting details.
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Figure 6. 
Non-covalent stabilization of the FF conformation can promote hyperoxidation. A. Protein 
surface area buried by crystal contacts (gray) has substantial overlap with magnitudes of 
conformation change (red) on a per residue basis along the chain. The CP (Cys48) and CR 
(Cys84) positions are denoted (*). Residues 79–81, not well defined in the LU structure, 
were assigned a shift of 10 Å based on their neighbors. B. One crystal contact region in the 
FF XcPrxQ crystals (white for main molecule and gray for symmetry mate) overlaid with 
LU structure (black) shows FF→LU movement (brown arrows) of Phe83 is prevented by a 
steric clash with Arg103 of the symmetry mate (red) because the two side chains would be 
1.3 Å apart. C. A general mechanism for Prx catalysis and hyperoxidation is shown, as has 
been previously proposed (Sevilla et al., 2015)(Perkins et al., 2015)(Perkins et al., 2014), 
that highlights the key physiologically-relevant redox states that have been captured at 
atomic resolution for XcPrxQ. Also emphasized is that inhibiting facile unfolding enhances 
inactivation. This has been observed to occur for sensitive Prx1-subfamily members by 
stabilization by the C-terminal tail (Wood et al., 2003). In the case of XcPrxQ, the FF crystal 
form can be conceptually considered as a large non-covalent FF-conformation-stabilizing 
inhibitor, trapping the enzyme as FF and promoting inactivation.
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